Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding

Constance C. F. M. J. Baaten, Stuart Meacham, Susanne M. de Witt, Marion A. H. Feijge, David J. Adams, Jan-Willem N. Akkerman, Judith M. E. M. Cosemans, Luigi Grassi, Steve Jupe, Myrto Kostadima, Nadine J. A. Mattheij, Martin H. Prins, Ramiro Ramirez-Solis, Oliver Soehnlein, Frauke Swieringa, Christian Weber, Jacqueline K. White, Willem H. Ouwehand, Johan W. M. Heemskerk

Blood (2018) 132 (24): e35–e46.

https://doi.org/10.1182/blood-2018-02-831982

Published: 2018

Includes: Supplemental data

Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2527.

https://doi.org/10.1182/blood-2018-99-113589

Published: 2018

Journal Articles

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Bruce L. Davidson, MD MPH, Philip S. Wells, MD FRCPC, MSc, Martin H. Prins, MD PhD, Jan Beyer-Westendorf, MD, Anthonie WA. Lensing, MD PhD, Lloyd Haskell, MD, Bennett Levitan, MD PhD, François Laliberté, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, Concetta Crivera, Patrick Lefebvre, MA, Qi Zhao, MPH, Zhong Yuan, MD PhD, Jeff Schein, Paolo Prandoni, MD PhD

Blood (2017) 130 (Supplement 1): 218.

https://doi.org/10.1182/blood.V130.Suppl_1.218.218

Published: 2017

Journal Articles

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

Ida Martinelli, Anthonie W. A. Lensing, Saskia Middeldorp, Marcel Levi, Jan Beyer-Westendorf, Bonno van Bellen, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Mila Trajanovic, Martin Gebel, Phuong Lam, Philip S. Wells, Martin H. Prins

Blood (2016) 127 (11): 1417–1425.

https://doi.org/10.1182/blood-2015-08-665927

Published: 2016

Journal Articles

Performance Of The Simplified Pesi Score In Patients With Pulmonary Embolism Treated With Rivaroxaban Or Standard Therapy

Petra MG Erkens, PhD, Gregory J Fermann, MD, FACEP, Martin H Prins, MD, Philip S Wells, MD, MSc, Akos F Pap, MSc, Anthonie WA Lensing, MD

Blood (2013) 122 (21): 1139.

https://doi.org/10.1182/blood.V122.21.1139.1139

Published: 2013

Journal Articles

Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial

Paolo Prandoni, Franco Noventa, Roberto Quintavalla, Carlo Bova, Benilde Cosmi, Sergio Siragusa, Eugenio Bucherini, Francesco Astorri, Stefano Cuppini, Fabio Dalla Valle, Anthonie W. A. Lensing, Martin H. Prins, Sabina Villalta

Blood (2012) 119 (6): 1561–1565.

https://doi.org/10.1182/blood-2011-11-391961

Published: 2012

Journal Articles

The EINSTEIN DVT Study: Does Localization of the Initial DVT Affect the Occurrence of Recurrent VTE While Patients Are on Anticoagulation?

Martin H Prins, Paolo Prandoni, Anthonie WA Lensing, Bonno van Bellen, Akos F Pap, Gary E Raskob, Harry R Büller

Blood (2011) 118 (21): 207.

https://doi.org/10.1182/blood.V118.21.207.207

Published: 2011

Journal Articles

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception

Elizabeth F. W. van Vlijmen, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Karina Meijer

Blood (2011) 118 (8): 2055–2061.

https://doi.org/10.1182/blood-2011-03-345678

Published: 2011

Journal Articles

Safety of Outpatient Treatment In Acute Pulmonary Embolism.

Petra MG Erkens, MSc, Esteban Gandara, MD, Phil Wells, MD, MSc, Alex Yi-Hao Shen, BSc, Gauruv Bose, Gregoire Le Gal, MD, PhD, Marc A. Rodger, MD, FRCPC, Martin H Prins, MD, PhD, Marc Carrier, MD, MSc

Blood (2010) 116 (21): 3796.

https://doi.org/10.1182/blood.V116.21.3796.3796

Published: 2010

Journal Articles

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Willem M. Lijfering, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Jan van der Meer

Blood (2009) 114 (10): 2031–2036.

https://doi.org/10.1182/blood-2009-04-215418

Published: 2009

Journal Articles

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

Willem M. Lijfering, Jan-Leendert P. Brouwer, Nic J. G. M. Veeger, Ivan Bank, Michiel Coppens, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Jan van der Meer

Blood (2009) 113 (21): 5314–5322.

https://doi.org/10.1182/blood-2008-10-184879

Published: 2009

Journal Articles

Idrabiotaparinux, a Biotinylated Long-Acting Anticoagulant, in the Treatment of Deep Venous Thrombosis (EQUINOX Study): Safety, Efficacy, and Reversibility by Avidin

Harry Roger Buller, MD, PhD, Jean-Michel Destors, Alexander S. Gallus, MD, Martin H Prins, MD, PhD, Gary Edward Raskob, PhD

Blood (2008) 112 (11): 32.

https://doi.org/10.1182/blood.V112.11.32.32

Published: 2008

Journal Articles

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

Hendrika M Knol, Nic J.G.M. Veeger, Saskia Middeldorp, Karly Hamulyàk, Martin H Prins, Harry R Büller, Jan van der Meer

Blood (2008) 112 (11): 1815.

https://doi.org/10.1182/blood.V112.11.1815.1815

Published: 2008

Journal Articles

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, Annelise Segers

Blood (2008) 112 (6): 2242–2247.

https://doi.org/10.1182/blood-2008-05-160143

Published: 2008

Includes: Supplemental data

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

Journal Articles

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

Bengt I. Eriksson, MD, PhD, Alexander G.G. Turpie, MD, PhD, Michael R. Lassen, MD, PhD, Martin H. Prins, MD, PhD, Giancarlo Agnelli, MD, PhD, Peter Kälebo, MD, PhD, Graham Wetherill, MSc, Lambertus Meems, MSc.

Blood (2007) 110 (11): 309.

https://doi.org/10.1182/blood.V110.11.309.309

Published: 2007

Journal Articles

Natural Course of the Subsequent Pregnancy after a Single Loss in Women with and without the Factor V Leiden or Prothrombin 20210A Mutations.

Michiel Coppens, Nienke Folkeringa, Margreet Teune, Karly Hamulyak, Jan van der Meer, Martin H. Prins, Harry R. Büller, Saskia Middeldorp

Blood (2006) 108 (11): 275.

https://doi.org/10.1182/blood.V108.11.275.275

Published: 2006

Journal Articles

A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation

Michiel Coppens, Marlene H. van de Poel, Ivan Bank, Karly Hamulyak, Jan van der Meer, Nic J. Veeger, Martin H. Prins, Harry R. Buller, Saskia Middeldorp

Blood (2006) 108 (8): 2604–2607.

https://doi.org/10.1182/blood-2006-04-016527

Published: 2006

Journal Articles

YM150, an Oral Direct Factor Xa Inhibitor, as Prophylaxis for Venous Thromboembolism in Patients with Elective Primary Hip Replacement Surgery. A Dose Escalation Study.

Bengt I. Eriksson, MD, Alexander G.G. Turpie, MD, Michael R. Lassen, MD, Martin H. Prins, MD, Giancarlo Agnelli, MD, Marleen L. Gaillard, PhD, Bert Meems, MSc

Blood (2005) 106 (11): 1865.

https://doi.org/10.1182/blood.V106.11.1865.1865

Published: 2005

Journal Articles

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

Marielle M.J. Beckers, MD, Roger E.G. Schutgens, MD, PhD, Martin H. Prins, MD, PhD, Douwe H. Biesma, MD, PhD

Blood (2005) 106 (11): 1623.

https://doi.org/10.1182/blood.V106.11.1623.1623

Published: 2005

NARROW

A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Healthcare Cost Impact of Continued Anticoagulation Therapy with Rivaroxaban Versus Aspirin for Prevention of Recurrent Symptomatic Venous Thromboembolism in the Einstein Choice Trial Population

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

Performance Of The Simplified Pesi Score In Patients With Pulmonary Embolism Treated With Rivaroxaban Or Standard Therapy

Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial

The EINSTEIN DVT Study: Does Localization of the Initial DVT Affect the Occurrence of Recurrent VTE While Patients Are on Anticoagulation?

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception

Safety of Outpatient Treatment In Acute Pulmonary Embolism.

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

Idrabiotaparinux, a Biotinylated Long-Acting Anticoagulant, in the Treatment of Deep Venous Thrombosis (EQUINOX Study): Safety, Efficacy, and Reversibility by Avidin

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal Loss.

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Once Daily YM150, an Oral Direct Factor Xa Inhibitor, for Prevention of Venous Thromboembolism in Patients Undergoing Elective Primary Hip Replacement.

Natural Course of the Subsequent Pregnancy after a Single Loss in Women with and without the Factor V Leiden or Prothrombin 20210A Mutations.

A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation

YM150, an Oral Direct Factor Xa Inhibitor, as Prophylaxis for Venous Thromboembolism in Patients with Elective Primary Hip Replacement Surgery. A Dose Escalation Study.

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only